Private Trust Co. NA reduced its position in shares of Danaher Corporation (NYSE:DHR) by 0.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,917 shares of the conglomerate’s stock after selling 164 shares during the period. Private Trust Co. NA’s holdings in Danaher Corporation were worth $1,596,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of DHR. Lee Danner & Bass Inc. raised its stake in Danaher Corporation by 0.4% in the first quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock worth $225,000 after buying an additional 10 shares in the last quarter. Rehmann Capital Advisory Group increased its position in Danaher Corporation by 0.6% in the first quarter. Rehmann Capital Advisory Group now owns 2,959 shares of the conglomerate’s stock worth $253,000 after buying an additional 19 shares during the last quarter. Guardian Life Insurance Co. of America increased its position in Danaher Corporation by 1.0% in the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock worth $202,000 after buying an additional 24 shares during the last quarter. Assetmark Inc. increased its position in Danaher Corporation by 0.5% in the first quarter. Assetmark Inc. now owns 6,622 shares of the conglomerate’s stock worth $566,000 after buying an additional 30 shares during the last quarter. Finally, Brown Capital Management LLC increased its position in Danaher Corporation by 0.8% in the first quarter. Brown Capital Management LLC now owns 3,946 shares of the conglomerate’s stock worth $338,000 after buying an additional 32 shares during the last quarter. 75.74% of the stock is currently owned by institutional investors.

Danaher Corporation (NYSE:DHR) traded down 0.12% on Wednesday, reaching $81.89. 697,670 shares of the company’s stock traded hands. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The company has a market cap of $56.89 billion, a PE ratio of 26.14 and a beta of 1.03. The firm’s 50 day moving average price is $82.08 and its 200 day moving average price is $84.16.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same period last year, the business posted $0.90 earnings per share. The firm’s revenue was up 6.3% compared to the same quarter last year. On average, equities analysts expect that Danaher Corporation will post $3.95 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Private Trust Co. NA Has $1.60 Million Position in Danaher Corporation (DHR)” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.watchlistnews.com/private-trust-co-na-has-1-60-million-position-in-danaher-corporation-dhr/1532276.html.

A number of research firms recently issued reports on DHR. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Zacks Investment Research downgraded shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Royal Bank Of Canada reiterated a “hold” rating and set a $88.00 target price on shares of Danaher Corporation in a research report on Wednesday, July 12th. Finally, Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $91.76.

In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now directly owns 155,520 shares in the company, valued at $12,718,425.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 27,808 shares of company stock valued at $2,296,236. Company insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.